BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 18434717)

  • 1. Mechanisms, risks, and new treatment options for hyponatremia.
    Ghali JK
    Cardiology; 2008; 111(3):147-57. PubMed ID: 18434717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current treatments and novel pharmacologic treatments for hyponatremia in congestive heart failure.
    Goldsmith SR
    Am J Cardiol; 2005 May; 95(9A):14B-23B. PubMed ID: 15847853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recognition and treatment of hyponatremia in acutely ill hospitalized patients.
    Patel GP; Balk RA
    Clin Ther; 2007 Feb; 29(2):211-29. PubMed ID: 17472815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin dysregulation and hyponatremia in hospitalized patients.
    Multz AS
    J Intensive Care Med; 2007; 22(4):216-23. PubMed ID: 17712057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasopressin excess and hyponatremia.
    Pham PC; Pham PM; Pham PT
    Am J Kidney Dis; 2006 May; 47(5):727-37. PubMed ID: 16632011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current issues for nurse practitioners: Hyponatremia.
    Haskal R
    J Am Acad Nurse Pract; 2007 Nov; 19(11):563-79. PubMed ID: 17970857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasopressin antagonists as aquaretic agents for the treatment of hyponatremia.
    Palm C; Pistrosch F; Herbrig K; Gross P
    Am J Med; 2006 Jul; 119(7 Suppl 1):S87-92. PubMed ID: 16843091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyponatremia: current treatment strategies and the role of vasopressin antagonists.
    Cawley MJ
    Ann Pharmacother; 2007 May; 41(5):840-50. PubMed ID: 17405824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyponatremia, heart failure, and the role of tolvaptan.
    O'Connell JB; Alemayehu A
    Postgrad Med; 2012 Mar; 124(2):29-39. PubMed ID: 22437213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Etiology, diagnostics and therapy of hyponatremias].
    Laczi F
    Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyponatremia in hospitalized patients: the potential role of tolvaptan.
    Deitelzweig SB; McCormick L
    Hosp Pract (1995); 2011 Aug; 39(3):87-98. PubMed ID: 21881396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasopressin dysregulation: hyponatremia, fluid retention and congestive heart failure.
    LeJemtel TH; Serrano C
    Int J Cardiol; 2007 Aug; 120(1):1-9. PubMed ID: 17346825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia.
    Zeltser D; Rosansky S; van Rensburg H; Verbalis JG; Smith N;
    Am J Nephrol; 2007; 27(5):447-57. PubMed ID: 17664863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyponatremic hypervolemia in heart failure--the hot spot for vasopressin receptor antagonists?].
    Dabrowska MD; Krysiak R; Okopień B
    Wiad Lek; 2012; 65(1):19-30. PubMed ID: 22827112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyponatremia, arginine vasopressin dysregulation, and vasopressin receptor antagonism.
    Rai A; Whaley-Connell A; McFarlane S; Sowers JR
    Am J Nephrol; 2006; 26(6):579-89. PubMed ID: 17170524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyponatremia and arginine vasopressin dysregulation: mechanisms, clinical consequences, and management.
    Miller M
    J Am Geriatr Soc; 2006 Feb; 54(2):345-53. PubMed ID: 16460390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyponatremia and hypernatremia: disorders of water balance.
    Agrawal V; Agarwal M; Joshi SR; Ghosh AK
    J Assoc Physicians India; 2008 Dec; 56():956-64. PubMed ID: 19322975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.
    Nemerovski C; Hutchinson DJ
    Clin Ther; 2010 Jun; 32(6):1015-32. PubMed ID: 20637957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyponatremia in psychiatric patients: update on evaluation and management.
    Siegel AJ
    Harv Rev Psychiatry; 2008; 16(1):13-24. PubMed ID: 18306096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial.
    Ginès P; Wong F; Watson H; Milutinovic S; del Arbol LR; Olteanu D;
    Hepatology; 2008 Jul; 48(1):204-13. PubMed ID: 18508290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.